FDA Puts Homeopathic Industry on Notice – No More Lax Enforcement

Agency Denies Industry Petition and Publishes Revised Draft Guidance The U.S. Food and Drug Administration (FDA) appears set to ramp up enforcement efforts against companies selling homeopathic products. Since 1988, FDA’s enforcement decisions have been made within the framework of Compliance Policy Guide (CPG) § 400.400. Under this policy, the agency generally limited enforcement actions…… Continue Reading